(ARWR) Arrowhead - Performance -36.6% in 12m
ARWR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.41%
#121 in Peer-Group
Rel. Strength
14.75%
#6533 in Stock-Universe
Total Return 12m
-36.56%
#103 in Peer-Group
Total Return 5y
-60.31%
#70 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 111 |
| High / Low | USD |
|---|---|
| 52 Week High | 29.54 USD |
| 52 Week Low | 9.99 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.89 |
| Buy/Sell Signal +-5 | -0.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARWR (-36.6%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARWR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARWR
| Total Return (including Dividends) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 16.33% | 4.10% | 4.77% |
| 3 Months | 48.38% | 13.70% | 16.02% |
| 12 Months | -36.56% | -12.86% | 12.44% |
| 5 Years | -60.31% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 70.5% | 52.1% | 90.3% |
| 3 Months | 86.9% | 79.4% | 97.5% |
| 12 Months | -82.2% | -87.4% | 46.4% |
| 5 Years | -91.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th79.50 | 11.75% | 11.03% |
| 3 Month | %th80.00 | 30.50% | 27.89% |
| 12 Month | %th49.00 | -27.19% | -43.58% |
| 5 Years | %th65.50 | -49.14% | -81.34% |
FAQs
Does Arrowhead (ARWR) outperform the market?
No,
over the last 12 months ARWR made -36.56%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months ARWR made 48.38%, while XBI made 13.70%.
Performance Comparison ARWR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARWR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.3% | 11.6% | -11.1% | -49% |
| US NASDAQ 100 | QQQ | 8.3% | 11% | -13.1% | -49% |
| German DAX 40 | DAX | 7.9% | 13.2% | -23.2% | -66% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.1% | 11.2% | -15.5% | -56% |
| Hongkong Hang Seng | HSI | 7.4% | 12.4% | -33.1% | -71% |
| India NIFTY 50 | INDA | 9.6% | 14.8% | -11.5% | -33% |
| Brasil Bovespa | EWZ | 12.5% | 16.7% | -26.1% | -37% |
ARWR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.7% | 12.7% | -14.4% | -60% |
| Consumer Discretionary | XLY | 7.3% | 11.5% | -3.4% | -53% |
| Consumer Staples | XLP | 10.3% | 15.8% | -10.1% | -44% |
| Energy | XLE | 5.3% | 14.3% | -3.5% | -37% |
| Financial | XLF | 9.7% | 11.6% | -13.4% | -60% |
| Health Care | XLV | 8.1% | 16.6% | 0.4% | -30% |
| Industrial | XLI | 7.9% | 10.7% | -16.9% | -58% |
| Materials | XLB | 7.6% | 11.1% | -11.7% | -40% |
| Real Estate | XLRE | 8.5% | 16.2% | -9.6% | -44% |
| Technology | XLK | 8.4% | 9.2% | -16.2% | -47% |
| Utilities | XLU | 8.2% | 14.4% | -15.1% | -59% |
| Aerospace & Defense | XAR | 7.6% | 9.1% | -31.1% | -84% |
| Biotech | XBI | 4.6% | 12.2% | -0.8% | -24% |
| Homebuilder | XHB | 5.2% | 5% | -4.5% | -34% |
| Retail | XRT | 8.3% | 9.5% | -6.2% | -43% |
ARWR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.7% | 20.0% | 2.84% | -33% |
| Natural Gas | UNG | 10% | 25.1% | 14.9% | -40% |
| Gold | GLD | 8.2% | 18.6% | -29% | -75% |
| Silver | SLV | 3.9% | 10.1% | -33.1% | -62% |
| Copper | CPER | -2.1% | 0.4% | -30.6% | -60% |
ARWR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.1% | 16.6% | -5.8% | -33% |
| iShares High Yield Corp. Bond | HYG | 8.8% | 15% | -8.1% | -45% |